---
figid: PMC5620322__oncotarget-08-69076-g001
figtitle: PRAS40 signaling in tumor
organisms:
- Moloney murine leukemia virus
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Drosophila melanogaster
- Volvox carteri
- NA
organisms_ner:
- Homo sapiens
- Mus musculus
- Drosophila melanogaster
- Rattus norvegicus
- Danio rerio
pmcid: PMC5620322
filename: oncotarget-08-69076-g001.jpg
figlink: /pmc/articles/PMC5620322/figure/F1/
number: F1
caption: (A) Stimuli such as insulin and IGF-1 activate PI3K/Akt pathway, resulting
  in the phosphorylation of PRAS40 and TSC2. Phosphorylation of both PRAS40 and TSC2
  reverses their suppression on the activation of mTOR pathway, including the phosphorylation
  of mTOR's downstream factors, such as 4E-BP1 and S6K. mTORC1 also phosphorylates
  PRAS40. The phosphorylation of PRAS40 promotes IRS1 expression and phosphorylation
  in turn through a positive control mechanism. (B) Unphosphorylated PRAS40 and TSC2
  repress mTORC1 signaling. (C) Under certain conditions, phosphorylated PRAS40 promotes
  the signaling of IR/PI3K/Akt pathway and mTOR pathway through increasing IR phosphorylation.
  PRAS40 could be either phosphorylated by PIM1, PKM2 and DYRK3. IGF-1, insulin-like
  growth factor-1; TSC2, tumor sclerosis complex 2; 4E-BP1, eukaryotic translation
  initiation factor 4E-binding protein 1; S6K, ribosomal protein S6 kinases; IR, insulin
  receptor; PIM1, Proviral integration site for Moloney murine leukemia virus-1; PKM2,
  Pyruvate kinase M2; DYRK3, The dual specificity tyrosine-phosphorylation-regulated
  kinase 3.
papertitle: PRAS40 signaling in tumor.
reftext: Dan Lv, et al. Oncotarget. 2017 Sep 15;8(40):69076-69085.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9058926
figid_alias: PMC5620322__F1
figtype: Figure
redirect_from: /figures/PMC5620322__F1
ndex: d41af3f4-df08-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5620322__oncotarget-08-69076-g001.html
  '@type': Dataset
  description: (A) Stimuli such as insulin and IGF-1 activate PI3K/Akt pathway, resulting
    in the phosphorylation of PRAS40 and TSC2. Phosphorylation of both PRAS40 and
    TSC2 reverses their suppression on the activation of mTOR pathway, including the
    phosphorylation of mTOR's downstream factors, such as 4E-BP1 and S6K. mTORC1 also
    phosphorylates PRAS40. The phosphorylation of PRAS40 promotes IRS1 expression
    and phosphorylation in turn through a positive control mechanism. (B) Unphosphorylated
    PRAS40 and TSC2 repress mTORC1 signaling. (C) Under certain conditions, phosphorylated
    PRAS40 promotes the signaling of IR/PI3K/Akt pathway and mTOR pathway through
    increasing IR phosphorylation. PRAS40 could be either phosphorylated by PIM1,
    PKM2 and DYRK3. IGF-1, insulin-like growth factor-1; TSC2, tumor sclerosis complex
    2; 4E-BP1, eukaryotic translation initiation factor 4E-binding protein 1; S6K,
    ribosomal protein S6 kinases; IR, insulin receptor; PIM1, Proviral integration
    site for Moloney murine leukemia virus-1; PKM2, Pyruvate kinase M2; DYRK3, The
    dual specificity tyrosine-phosphorylation-regulated kinase 3.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IRS1
  - TSC2
  - AKT1S1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - RHEB
  - RHEBP1
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - RPTOR
  - RPS6KB1
  - PIM1
  - LONP1
  - PKM
  - PKLR
  - EIF4EBP1
  - Igf1
  - Irs1
  - Tsc2
  - Akt1s1
  - Pik3r1
  - Rheb
  - Akt1
  - Rps6kb1
  - Pim1
  - Pkm
  - Eif4ebp1
  - gig
  - PRAS40
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - Crtc
  - S6k
  - Thor
  - Pik3cg
  - igf1
  - irs1
  - tsc2
  - rheb
  - rhebl1
  - pim1
  - pim2
  - pkma
  - Cancer
---
